About the Journal
"[T]he simple word Care may suffice to express [the journal’s] philosophical mission", "to promote better patient care by serving the expanded needs of all health professionals committed to the care of patients with diabetes." More.
2022 JCR Metrics
Impact Factor 16.2 (6th)
Total Citations 83,788 (2nd)
Eigenfactor 0.07696 (1st)
Learn More

Diabetes Care "On Air"
Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they interview authors and discuss the latest high-impact research published in each monthly issue of Diabetes Care. Available from most podcasting platforms.
Listen and follow today on Apple Podcasts | Google Play | Amazon Music | Spotify
Current Issue Highlights
Volume 46, Issue 10

Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes


Submit your artwork for the cover of Diabetes Care
Calling all artists impacted by diabetes! Please consider submitting your original artwork for publication on the cover of an issue of Diabetes Care. Any subject or medium is welcome. Learn more.

Follow Diabetes Care on Twitter
Join us on Twitter @DiabetesCareADA to learn about recently published articles, along with your diabetes research community, and share ideas with fellow professionals. Find the newest published articles, information on related ADA podcasts, new professional book titles, and up-to-date diabetes news items. You can also follow ADA Publications on Facebook @adaPublications.
“Social Determinants of Health: Impact on Diabetes Development and Care,” Diabetes Care Symposium 2023
This timely collection includes articles presented at ADA’s annual Scientific Sessions on 23 June 2023, as part of Diabetes Care Symposium “Social Determinants of Health: Impact on Diabetes Development and Care.” Together the articles synthesize and discuss available evidence relating social, political, and commercial determinants of health and the risk and outcomes of type 2 diabetes. Access is free.

NEW Standards of Care in Diabetes Clinical Practice Guideline Updates From the American Diabetes Association
On 25 June 2023, ADA released important updates to the Standards of Care in Diabetes, the most comprehensive, evidence-based guidelines for the prevention, diagnosis, and treatment of diabetes. New guidelines include recommendations on teplizumab for delaying type 1 diabetes (Section 2 and Section 3) and recommendations for the detection and management of NAFLD/NASH (Section 4).
Access is free.